Concepedia
Statistics
Publications
10
Citations
2.2K
H-Index
Active since
1995
Affiliations
Harvard University(Current)
Massachusetts General Hospital
Novartis (Switzerland)
Brigham and Women's Hospital
Millennium Engineering and Integration (United States)
YongYao Xu is an author at Harvard University specializing in medicine, signal transduction, and cell biology.
Top concepts
MedicineCell BiologyCell SignalingSignal TransductionImmunologyDementiaNeurologyCell DeathInflammationNeuroscience
Publications per year
1995–2023
The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling
Hidetoshi Hayashi, Shirin Abdollah, Yubin Qiu et al. · Cell · 1997 · 1.3K citations · Full text
Signal Transduction, Immunology, Tgfβ Receptor +5
Vascular <i>MAD</i> s: Two novel <i>MAD</i> -related genes selectively inducible by flow in human vascular endothelium
James N. Topper, Jiexing Cai, Yubin Qiu et al. · Proceedings of the National Academy of Sciences · 1997 · 323 citations · Full text
Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function
Jennifer L. Brogdon, YongYao Xu, Susanne J. Szabo et al. · Blood · 2006 · 226 citations · Full text
PIKfyve, a Class III PI Kinase, Is the Target of the Small Molecular IL-12/IL-23 Inhibitor Apilimod and a Player in Toll-like Receptor Signaling
Xinming Cai, YongYao Xu, Atwood K. Cheung et al. · Chemistry & Biology · 2013 · 219 citations · Full text
Inflammation, Cytokine, Signal Transduction +8
PIKfyve, a Class III Lipid Kinase, Is Required for TLR-Induced Type I IFN Production via Modulation of ATF3
Xinming Cai, YongYao Xu, You‐Me Kim et al. · The Journal of Immunology · 2014 · 45 citations · Full text
1–5 of 10